Mon, Jan 23, 2017 at noon:
H. Luke Shaefer
Naylor, M., J. Karlawish, S. Arnold, A. Khachaturian, Z. Khachaturian, V. Lee, M. Baumgart, S. Banerjee, C. Beck, K. Blennow, R. Brookmeyer, K. Brunden, K. Buckwalter, M. Comer, K. Covinsky, L. Feinberg, G. Frisoni, C. Green, R. Guimaraes, L. Gwyther, F. Hefti, M. Hutton, C. Kawas, D. Kent, L. Kuller, Kenneth M. Langa, R. Mahley, K. Maslow, C. Masters, D. Meier, P. Neumann, S. Paul, R. Petersen, M. Sager, M. Sano, D. Schenk, H. Soares, R. Sperling, S. Stahl, V. van Deerlin, Y. Stern, David Weir, D. Wolk, and J. Trojanowski. 2012. "Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit." Alzheimer's and Dementia, 8(5): 445-52.
To address the pending public health crisis due to Alzheimer's disease (AD) and related neurodegenerative disorders, the Marian S. Ware Alzheimer Program at the University of Pennsylvania held a meeting entitled "State of the Science Conference on the Advancement of Alzheimer's Diagnosis, Treatment and Care," on June 21-22, 2012. The meeting comprised four workgroups focusing on Biomarkers; Clinical Care and Health Services Research; Drug Development; and Health Economics, Policy, and Ethics. The workgroups shared, discussed, and compiled an integrated set of priorities, recommendations, and action plans, which are presented in this article.
PMCID: PMC3552530. (Pub Med Central)